Point72 Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.14M Buy
+44,800
New +$4.5M 0.01% 1829
2024
Q2
Sell
-300,000
Closed -$6.19M 2070
2024
Q1
$6.19M Buy
+300,000
New +$6.43M 0.02% 899
2023
Q1
Sell
-7,500
Closed -$204K 2352
2022
Q4
$204K Buy
+7,500
New +$343K ﹤0.01% 1260

Other funds holding GH

Point72 Asset Management's GH Position: Q1 2026 in Review

Point72 Asset Management reduced its Guardant Health (GH) stake by 54% in Q1 2026, selling an estimated $80.6M and leaving 695,940 shares worth $64.3M. The position accounts for 0.08% of the portfolio, ranked #282.

Point72 Asset Management first reported a position in GH in Q1 2019 and has held it in 19 quarters since. The position peaked at $153M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Point72 Asset Management held 695,940 shares of Guardant Health worth $64.3M as of Q1 2026.
  • Point72 Asset Management sold 803,229 Guardant Health shares in Q1 2026, an estimated $80.6M.
  • Guardant Health made up 0.08% of Point72 Asset Management's portfolio in Q1 2026, its #282 holding.
  • Point72 Asset Management first reported a position in Guardant Health in Q1 2019 and has held it in 19 quarters since.
  • Point72 Asset Management's Guardant Health position peaked at $153M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.